Antiangiogenic Synergism of Integrin-Targeted Fumagillin Nanoparticles and Atorvastatin in Atherosclerosis

OBJECTIVE: Studies were performed to develop a prolonged antiangiogenesis therapy regimen based on theranostic α(ν)β(3)–targeted nanoparticles. BACKGROUND: Antiangiogenesis therapy may normalize atherosclerotic plaque vasculature and promote plaque stabilization.α(ν)β(3)–targeted paramagnetic nanopa...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Winter, Patrick M., Caruthers, Shelton D., Zhang, Huiying, Williams, Todd A., Wickline, Samuel A., Lanza, Gregory M.
Formato: Artigo
Idioma:Inglês
Publicado: 2008
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2636718/
https://ncbi.nlm.nih.gov/pubmed/19356492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcmg.2008.06.003
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares